Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transder...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Emre, Murat, Bernabei, Roberto, Blesa, Rafael, Bullock, Roger, Cunha, Luis, Daniëls, Hugo, Dziadulewicz, Edward, Förstl, Hans, Frölich, Lutz, Gabryelewicz, Tomasz, Levin, Oleg, Lindesay, James, Martínez‐Lage, Pablo, Monsch, Andreas, Tsolaki, Magda, Van Laar, Teus
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2010
Assuntos:
Alzheimer's Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493902/
https://ncbi.nlm.nih.gov/pubmed/20370805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00141.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados